Research Article

Evaluation of Azathioprine-Induced Cytotoxicity in an In Vitro Rat Hepatocyte System

Table 1

AZA-induced oxidative stress with GSH depletion and protection with a GSH precursor, a xanthine oxidase inhibitor, various antioxidants, and a radical scavenger.

AdditionROS (FI unit)MMP (%)H2O2 (nmoles/106 cells)

Incubation time30 min30 min30 min

Control102 ± 11006.34 ± 0.07
 +400 μM AZA139 ± 3a86 ± 1a8.11 ± 0.08a
  +GSH-depleted hepatocytes174 ± 5a,b75 ± 1a,b9.21 ± 0.13a,b
  +1 mM NAC124 ± 3a,b89 ± 1a6.97 ± 0.04a,b
  +20 μM allopurinol132 ± 3a92 ± 1a,b7.75 ± 0.19a
  +1 mM NAC + 20 μM allopurinol107 ± 1b97 ± 2b6.54 ± 0.14b
  +1 mM mesna121 ± 3a,b93 ± 2a,b7.10 ± 0.18a,b
  +1 mM Trolox113 ± 3b94 ± 2a,b7.12 ± 0.02a,b
  +200 μM TEMPOL123 ± 4a,b93 ± 1a,b7.46 ± 0.18a,b
  +2 μM DPPD124 ± 2a,b92 ± 2a,b7.26 ± 0.06a,b

Data are presented as mean ± SEM ( ). All modulating agents were noncytotoxic compared to control hepatocytes at concentrations used. Refer to Section 2 for a description of the experiments performed and experimental conditions. FI, fluorescence intensity; NAC, N-acetylcysteine; mesna, 2-mercaptoethanesulfonate; Trolox, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid; TEMPOL, 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl; DPPD, N,N′-diphenyl-p-phenylenediamine; significant compared to control (only hepatocytes); significant compared to 400 μM AZA.